BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20868557)

  • 41. Long-term results of concurrent chemoradiotherapy with daily-low-dose continuous infusion of 5-fluorouracil and cisplatin (LDFP) for Stage I-II esophageal carcinoma.
    Kumabe A; Fukada J; Kota R; Koike N; Shiraishi Y; Seki S; Yoshida K; Kitagawa Y; Shigematsu N
    Dis Esophagus; 2018 Apr; 31(4):. PubMed ID: 29228166
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term results of paclitaxel plus cisplatin with concurrent radiotherapy for loco-regional esophageal squamous cell carcinoma.
    Zhu HT; Ai DS; Tang HR; Badakhshi H; Fan JH; Deng JY; Zhang JH; Chen Y; Zhang Z; Xia Y; Guo XM; Jiang GL; Zhao KL
    World J Gastroenterol; 2017 Jan; 23(3):540-546. PubMed ID: 28210091
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systematic Review and Meta-analysis of Conventionally Fractionated Concurrent Chemoradiotherapy versus Altered Fractionation Radiotherapy Alone in the Definitive Management of Locoregionally Advanced Head and Neck Squamous Cell Carcinoma.
    Gupta T; Kannan S; Ghosh-Laskar S; Agarwal JP
    Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):50-61. PubMed ID: 26454839
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radiotherapy and chemotherapy in locally advanced non-small cell lung cancer: preclinical and early clinical data.
    Reboul FL
    Hematol Oncol Clin North Am; 2004 Feb; 18(1):41-53. PubMed ID: 15005280
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of Qingfei Quyu Decoction in Prevention of Radiation Pneumonitis Induced by Concurrent Chemoradiotherapy for Esophageal Carcinoma Patients].
    Cui Z; Liu W; Yin HM; Li DJ; Liu JJ; Shen XM; Peng KG; Jiang H
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Mar; 36(3):317-21. PubMed ID: 27236889
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduced toxicity with three-dimensional conformal radiotherapy or intensity-modulated radiotherapy compared with conventional two-dimensional radiotherapy for esophageal squamous cell carcinoma: a secondary analysis of data from four prospective clinical trials.
    Deng JY; Wang C; Shi XH; Jiang GL; Wang Y; Liu Y; Zhao KL
    Dis Esophagus; 2016 Nov; 29(8):1121-1127. PubMed ID: 26663710
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Short-term efficacy of intensity-modulated radiotherapy on esophageal carcinoma].
    Wang J; Han C; Li XN; Gao C; Jia JH; Cai BN; Zhang X; Xiao AQ
    Ai Zheng; 2009 Nov; 28(11):1138-42. PubMed ID: 19895732
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Three-Dimensional Radiation Therapy to the Primary Tumor With Concurrent Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer: Results of a Multicenter Phase 2 Study From PPRA-RTOG, China.
    Su S; Li T; Lu B; Wang X; Li J; Chen M; Lu Y; Bai Y; Hu Y; Ouyang W; Ma Z; Li Q; Li H; Wang Y
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):769-77. PubMed ID: 26530745
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Concurrent chemoradiotherapy for cervical esophageal squamous cell carcinoma: treatment results from a prospective observational study.
    Li HX; Liu J; Cheng Y; Liu MN; Fang WT; Lv CX
    Dis Esophagus; 2018 May; 31(5):. PubMed ID: 29294022
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chemoradiotherapy for esophageal squamous cell cancer.
    Sasaki Y; Kato K
    Jpn J Clin Oncol; 2016 Sep; 46(9):805-10. PubMed ID: 27380810
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preoperative hyperfractionated radiotherapy with concurrent chemotherapy in resectable esophageal cancer.
    Kim JH; Choi EK; Kim SB; Park SI; Kim DK; Song HY; Jung HY; Min YI
    Int J Radiat Oncol Biol Phys; 2001 May; 50(1):1-12. PubMed ID: 11316540
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Concurrent radiotherapy and chemotherapy with protracted continuous infusion of 5-fluorouracil in inoperable esophageal squamous cell carcinoma.
    Sakai K; Inakoshi H; Sueyama H; Oda J; Ito T; Tsuchida E; Sugita T; Matsumoto Y; Saito M; Saito A
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):921-7. PubMed ID: 7860407
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Late course accelerated hyperfractionated radiotherapy for clinical T1-2 esophageal carcinoma.
    Zhao KL; Wang Y; Shi XH
    World J Gastroenterol; 2003 Jun; 9(6):1374-6. PubMed ID: 12800260
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcomes from chemoradiotherapy for patients with esophageal cancer.
    Pantling AZ; Gossage JA; Mamidanna R; Newman G; Robinson A; Manifold DK; Hale PC
    Dis Esophagus; 2011 Apr; 24(3):172-6. PubMed ID: 21073614
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up.
    Zemanova M; Petruzelka L; Pazdro A; Kralova D; Smejkal M; Pazdrova G; Honova H
    Dis Esophagus; 2010 Feb; 23(2):160-7. PubMed ID: 19515190
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Late-course accelerated Hyperfractionation vs. Conventional Fraction Radiotherapy under precise technology plus Concurrent Chemotherapy for Esophageal Squamous Cell Carcinoma: comparison of efficacy and side effects.
    Luo H; Wei S; Wang X; Liu R; Zhang Q; Yang Z; Li Z; Wei X; Qi Y; Xu L
    J Cancer; 2020; 11(10):3020-3026. PubMed ID: 32226517
    [No Abstract]   [Full Text] [Related]  

  • 57. Esophageal cancer located at the neck and upper thorax treated with concurrent chemoradiation: a single-institution experience.
    Wang S; Liao Z; Chen Y; Chang JY; Jeter M; Guerrero T; Ajani J; Phan A; Swisher S; Allen P; Cox JD; Komaki R
    J Thorac Oncol; 2006 Mar; 1(3):252-9. PubMed ID: 17409865
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A phase III study of accelerated radiotherapy with and without carboplatin in nonsmall cell lung cancer: an interim toxicity analysis of the first 100 patients.
    Ball D; Bishop J; Smith J; Crennan E; O'Brien P; Davis S; Ryan G; Joseph D; Walker Q
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):267-72. PubMed ID: 7836079
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Value of postoperative radiochemotherapy for thoracic esophageal squamous cell carcinoma with lymph node metastasis].
    Lin Y; Chen J; Li J; Liu J; Zhu K; Pan C; Chen M; Pan J
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):151-4. PubMed ID: 24796467
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aggressive concurrent chemoradiotherapy and surgical resection for proximal esophageal squamous cell carcinoma.
    Adelstein DJ; Rice TW; Tefft M; Koka A; Van Kirk MA; Kirby TJ; Taylor ME
    Cancer; 1994 Sep; 74(6):1680-5. PubMed ID: 8082068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.